Don't want ads? Subscribe or login now.

Merck Nixes Some Actions in Vioxx Securities Fraud Battle

By Cara Salvatore · June 19, 2015, 9:33 PM EDT

A New Jersey federal judge partially dismissed seven actions Friday within sprawling securities fraud litigation alleging Merck & Co. misrepresented the heart-attack risk of its arthritis drug Vioxx but said some...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

MERCK & CO., INC., SECURITIES, DERIVATIVE & "ERISA" LITIGATION

Case Number

2:05-cv-01151

Court

New Jersey

Nature of Suit

Labor: Other

Date Filed

February 28, 2005

Recent Articles By Cara

May 29, 2024
Weinstein Could Face Added Assault Charges In Retrial
April 30, 2024
Detroit Tigers Say Fired Workers Can't Testify At Age Bias Trial
March 15, 2024
Tesla Owes $42.5M To Injured Motorcyclist, Jury Says
January 31, 2024
When Managing Partners Watch, Trial Attys Face 2 Juries
December 19, 2023
Error-Filled Employment Trial Transcript Replaced By Judge
November 09, 2023
De Niro Cleared, Production Co. Owes $1.2M In Bias Trial
November 08, 2023
De Niro Should Pay Millions In Bias Trial, Jury Hears
November 07, 2023
De Niro Aide Suffered Work Anxiety, Jury Told
November 06, 2023
De Niro Ex-Aide Says She Was 'Humiliated' By Shift In Duties
November 03, 2023
De Niro's Gender Bias Included Inferior Pay, Jury Hears